46 By 2021, semaglutide (Wegovy , Novo Nordisk) administered by subcutaneous injection was also approved by the US FDA as an obesity treatment (Table 1)
The ClinicalTrials.gov registration A study titled "Effectiveness of Microdosed GLP-1 in Improving Health" (NCT07092605) is registered on ClinicalTrials.gov, suggesting that formal clinical investigation into microdosed GLP-1 approaches is underway
Communities with less consistent access to primary care are the ones most likely to fall through the cracks of a program that on paper is supposed to help them, said Cody Stanford
The study indicates this may not be because the patients aren't producing enough glutathione, it may be because glutathione is being used at a higher rate in patients with type II diabetes
The median time from breast cancer diagnosis to GLP-1 RA initiation was 4.3 years (range, 4.4 to 29.5), and the median duration of GLP-1 RA use was 20 months (range, 6-111 months)